Laser Indirect Ophthalmoscope Market is expanding rapidly with Heine introducing Omega 600 lightweight indirect ophthalmoscope

 

A laser indirect ophthalmoscope (or simply a laser ophthalmoscope as it is also known) is a lens that allows the doctor to see into a patient's eye without having to make direct contact with it. This has a number of advantages, both financially and as a patient, and these benefits are summed up below. When it comes to regional impact, North America is likely to exhibit high traction in the laser indirect ophthalmoscope market. This is due to the fact that increasing product launches and the presence of a large pool of patients in the region. Besides, Asia Pacific is registering lucrative signs due to improving disposable income.

Ophthalmoscope devices have evolved over the years with technological advancements and continuous R&D activities. As a matter of fact, laser indirect ophthalmoscopy provides critical advantages including better image resolution, less irritation to the ocular surface, and a wider field of view. Recently, in October 2020, Norlase received the U.S. Food and Drug Administration (FDA) for its Norlase LION, a green laser photocoagulator fully integrated with Keeler indirect ophthalmoscope. Hence, such factors can augment growth of the laser indirect ophthalmoscope market.

The major benefit of using a laser ophthalmoscope is the large working distance that it provides compared to conventional methods. It is now possible to achieve a working distance of up to two feet or more when using a laser ophthalmoscope. The best way to achieve this working distance is by choosing a model that has a good optical system. That being said, there are several factors that could still limit growth of the market. For instance, product recalls by regulatory authorities or by manufacturers themselves remain one of the key hurdles in the market. Besides, the high capital cost of these devices can impede growth of the laser indirect ophthalmoscope market.

Another key benefit of using a laser delivery system, which is sometimes referred to as a binocular indirect ophthalmoscope, is that it provides an extremely fast image acquisition speed. Diabetic retinopathy is an eye disease with a high rate of complication due to poor image quality; this disease can occur even with low-cost laser delivery systems. Over the years, the prevalence of ophthalmic disorders that requires immediate diagnosis and treatment. As per the Centers for Disease Control and Prevention (CDC), around 12 million people aged 40 years and above suffer from vision impairment every year in the U.S. As a result of this, the indirect of ophthalmoscope devices has increased. Therefore, such factors can potentially stimulate growth of the laser indirect ophthalmoscope market in the near future. Recently, in February 2021, Heine launched Omega 600 lightweight indirect ophthalmoscope.